Compare stocks

MedCap AB, established in 2001 and headquartered in Stockholm, Sweden, is a private equity firm specializing in the acquisition and development of small to medium-sized companies within the life sciences sector. The firm focuses on three primary business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap's portfolio includes subsidiaries such as Abilia, which operates in assistive technology; Cardiolex, specializing in ECG solutions; and Unimedic, involved in specialty pharmaceuticals. The company primarily targets investments in Northern Europe, aiming to support businesses with international growth potential. MedCap typically acquires majority stakes, providing capital, expertise, and networks to foster long-term development.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.